Unexpected findings with apomorphine and their possible consequences.

作者信息

Cotzias G C, Mena I, Papavasiliou P S, Mendez J

出版信息

Adv Neurol. 1974;5:295-9.

PMID:4440577

Abstract

摘要

相似文献

Unexpected findings with apomorphine and their possible consequences.

Adv Neurol. 1974;5:295-9.

Levodopa, manganese, and degenerations of the brain.

Harvey Lect. 1974;68:115-47.

['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine].

Ned Tijdschr Geneeskd. 1990 May 5;134(18):889-91.

Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.

Mov Disord. 2006 Sep;21(9):1523-5. doi: 10.1002/mds.20975.

Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.

Mov Disord. 2002 Nov;17(6):1235-41. doi: 10.1002/mds.10281.

[Long-term results of continuous subcutaneous apomorphine pump therapy in patients with advanced Parkinson disease].

Nervenarzt. 1993 Apr;64(4):221-5.

Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.

J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1024-6. doi: 10.1136/jnnp.55.11.1024.

Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.

Acta Neurol Scand. 2009 May;119(5):345-8. doi: 10.1111/j.1600-0404.2008.01104.x. Epub 2008 Sep 25.

Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.

N Engl J Med. 1976 Mar 11;294(11):567-72. doi: 10.1056/NEJM197603112941101.

Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.

J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):372-3. doi: 10.1136/jnnp.54.4.372.

引用本文的文献

Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease.

CNS Drugs. 1996 May;5(5):369-88. doi: 10.2165/00023210-199605050-00006.

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.

J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573.

Suppression of REM rebound by Pergolide.

J Neural Transm. 1984;59(2):151-9. doi: 10.1007/BF01255413.

Effects of DA agonist in Huntington disease hyperkinesia.

Ital J Neurol Sci. 1980 Jun;1(3):155-61. doi: 10.1007/BF02335845.

Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Psychopharmacology (Berl). 1977 Jun 6;53(1):45-53. doi: 10.1007/BF00426693.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验